Publications by authors named "Kirk Stevens"

Claim this Profile
T
The Discovery of GS-1291269: A Neutral Ketohexokinase (KHK) Inhibitor with an Unusual Thietane Amine Functional Group.
Zachary A Kasun, Xiaomin Liang, Ryan D Ferrao, Joshua A Kaplan, Christopher T Clark, Kirk L Stevens

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of palpatory acuity in chiropractic students between 2015 and 2024.
Alice Cade, Kirk Stevens, Jens Duehr, Katie Marten, Imran Khan Niazi

BMC Med Educ· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in chiropractic students pre- and post-COVID-19 lockdowns utilizing the Short-Form Health Survey-36.
Alice E Cade, Imran Khan Niazi, Elly Whittaker, Reid Midanik, Kirk Stevens

J Chiropr Educ· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking the cycle of reoccurring low back pain with integrated motivational interviewing and cognitive behavioural therapy to facilitate education and exercise advice: a superiority randomised controlled trial study protocol.
Estelle D Watson, Paul W Marshall, Natalie M V Morrison, Niamh Moloney, Paul O'Halloran, Kirk Stevens

BMC Public Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in learning retention and experience of augmented reality notes compared to traditional paper notes in a chiropractic technique course: A randomized trial.
Alice E Cade, Kirk Stevens, Alan Lee, Lisa Baptista

J Chiropr Educ· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors.
Leena Patel, Jayaraman Chandrasekhar, Jerry Evarts, Aaron C Haran, Carmen Ip, Kirk L Stevens

J Med Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
Samarjit Patnaik, Kirk L Stevens, Roseanne Gerding, Felix Deanda, J Brad Shotwell

Bioorg Med Chem Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.
Alex G Waterson, Kimberly G Petrov, Keith R Hornberger, Robert D Hubbard, Douglas M Sammond, Kirk L Stevens

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
Kyle A Emmitte, Brian J Wilson, Erich W Baum, Holly K Emerson, Kevin W Kuntz, Kirk L Stevens

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.
Kirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, Thomas R Caferro, Stanley D Chamberlain

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase.
Stanley D Chamberlain, Joseph W Wilson, Felix Deanda, Samarjit Patnaik, Anikó M Redman, Kirk L Stevens

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
Stanley D Chamberlain, Anikó M Redman, Joseph W Wilson, Felix Deanda, J Brad Shotwell, Kirk L Stevens

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.
Stanley D Chamberlain, Anikó M Redman, Samarjit Patnaik, Keith Brickhouse, Yen-Chiat Chew, Kirk L Stevens

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible carboxamide-mediated internal activation at C(6) of 2-chloro-4-anilino-1H-pyrrolo[2,3-d]pyrimidines.
Stanley D Chamberlain, Roseanne M Gerding, Huangshu Lei, Ganesh Moorthy, Samarjit Patnaik, Kirk L Stevens

J Org Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.
Kirk L Stevens, Michael J Reno, Jennifer B Alberti, Daniel J Price, Laurie S Kane-Carson

Bioorg Med Chem Lett· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors.
Alex G Waterson, Kirk L Stevens, Michael J Reno, Yue-Mei Zhang, Eric E Boros

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors.
Kirk L Stevens, David K Jung, Michael J Alberti, Jennifer G Badiang, Gregory E Peckham

Org Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis